Menu Search
Equities

Allegra Medical Technologies Ltd

ALOLF:PKC

Allegra Medical Technologies Ltd

Actions
  • Price (USD)0.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Dec 30 1899.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Allegra Medical Technologies Limited, formerly Allegra Orthopaedics Limited, is a biotechnology company. The Company is engaged in the medical device industry with its pioneering three dimensional (3D)-printed Sr-HT and Sr-HT-Gahnite orthopedic devices. It holds exclusive ownership of bio ceramic material, along with registered patents and patent applications from the University of Sydney. This material has several applications, including its use as a cervical fusion cage in spinal surgery, offering treatment options for patients. The Company is developing Sr-HT ceramic material to demonstrate the bioactivity required for bone regeneration. Sr-HT-Gahnite features bioactivity, biocompatibility, and mechanical properties suitable for load- bearing orthopedic implants. The primary focus centers on commercializing the Sr-HT Gahnite Bone substitute.

  • Revenue in AUD (TTM)-1.07m
  • Net income in AUD-2.69m
  • Incorporated1994
  • Employees4.00k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.